Search & Analyze

Apollo Hospitals Enterprise Ltd.

8,400.00+202.00 (+2.46%)

BSE · 30 Oct, 4:01 PM

: ₹1,20,779.11 Cr
: 57.80
: 19,294
: ₹8,400.00 - ₹8,173.40
: ₹9,326.80 - ₹6,680.00

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) share price closed at ₹8,400.00 on the BSE on Friday, October 30, 2026, up by 2.46% from its of ₹8,198.00. In that session APOLLOHOSP reached a of 8,400.00 and of 8,173.40. The for the session was 8,311.76. The stands at 8,429.47 and is at 8,092.71. Looking at , the stock ended the session in Uptrend.

Stock Overview

₹8,205.00

₹8,198.00

₹8,311.76

₹8,429.47

Price 0.35% below

₹8,092.71

Price 3.80% above

Key Fundamentals

: 1,20,779.11 Cr₹1.21 Lakh Crore
: 145.32
: 57.80
: 12.47
: 673.58
: 4,209.70 Cr₹4.21 Thousand Crore
: 0.24 %
Sector
Industry: Hospital & Healthcare Services
: 23.54
: 0.62

Industry Comparison

Ratio	Company	Sector
	57.80	44.77
	0.62	0.20
	12.47	4.61
	1.06	1.81
	0.24 %	0.11 %
Operating Margin	14.94 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
Apollo Hospitals Enterprise Ltd. APOLLOHOSP	8,400.00	57.80	1,20,779.11	0.24	610.40	38.41%	7,043.50	20.56%	21.73
MANIPALHOS MANIPALHOS	668.45	98.54	87,926.39	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
MAXHEALTH MAXHEALTH	860.00	60.63	83,706.13	0.23	414.45	-15.64%	2,569.21	20.31%	14.97
ASTERDM ASTERDM	680.40	186.93	59,308.59	0.44	29.28	-68.70%	1,310.68	21.60%	16.22
FORTIS FORTIS	769.80	55.46	58,116.68	0.13	272.80	2.26%	2,545.03	17.46%	14.07
NH NH	1,700.00	43.06	34,741.34	0.26	301.15	16.50%	2,843.99	73.01%	16.20
MEDANTA MEDANTA	1,265.00	61.35	34,013.01	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
LALPATHLAB LALPATHLAB	1,892.90	59.05	31,772.10	1.08	170.50	27.24%	797.70	19.10%	29.56

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	3,638.93	3,546.43	3,795.60	4,251.10	4,263.58	4,302.20	4,417.80	4,846.90	4,943.90	5,085.60	5,589.30	5,526.90	5,592.20	5,842.10	6,303.50	6,477.40	6,605.50	7,043.50
Expenses	3,051.90	3,083.20	3,304.80	3,685.70	3,758.23	3,814.05	3,908.80	4,219.40	4,303.40	4,410.50	4,773.80	4,765.40	4,822.50	4,990.20	5,362.40	5,512.10	5,594.50	5,951.40
	587.03	463.23	490.80	565.40	505.35	488.15	509.00	627.50	640.50	675.10	815.50	761.50	769.70	851.90	941.10	965.30	1,011.00	1,092.10
	16.13%	13.06%	12.93%	13.30%	11.85%	11.35%	11.52%	12.95%	12.96%	13.27%	14.59%	13.78%	13.76%	14.58%	14.93%	14.90%	15.31%	15.51%
	17.15	30.72	16.10	22.60	35.36	16.35	28.20	24.10	28.10	37.20	38.20	63.80	61.10	40.20	54.70	33.60	43.90	48.80
Interest	93.67	94.90	92.70	92.70	99.96	95.41	106.20	111.30	119.30	116.40	117.50	109.80	114.80	108.30	109.60	112.60	119.10	120.40
	148.99	166.40	147.80	155.00	153.39	159.06	166.90	163.40	189.70	177.40	184.50	184.60	211.00	214.70	217.80	219.20	224.40	235.10
	367.47	235.67	254.40	327.10	265.82	253.60	270.00	379.00	368.20	430.00	557.40	536.20	515.50	582.70	674.70	682.00	721.50	798.80
	33.80%	58.84%	-27.32%	34.94%	38.94%	42.57%	35.78%	34.35%	29.82%	26.63%	29.01%	29.24%	19.59%	24.32%	26.78%	24.30%	23.59%	23.59%
	228.37	90.14	317.20	204.00	153.46	144.52	166.60	232.90	253.80	305.20	378.80	372.30	389.60	432.80	477.20	502.30	529.30	580.70
	15.88	6.27	22.06	14.19	10.67	10.05	11.59	16.20	17.65	21.23	26.34	25.89	27.09	30.10	33.19	34.93	36.81	40.39

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	14,662.60	16,612.50	19,059.20	21,794.00	25,228.50
Operating Income (Net)	14,662.60	16,612.50	19,059.20	21,794.00	25,228.50
EXPENDITURE :
Cost of Medicines and Consumables	7,573.50	8,574.30	9,805.50	11,310.00	13,075.60
Power & Fuel Cost	193.70	217.50	247.20	266.20	281.40
Employee Cost	1,786.50	2,176.70	2,493.70	2,769.20	3,000.30
Hospital Operation Expenses	776.70	1,981.00	2,290.90	2,612.00	3,182.30
Selling, Administration and Other Expenses	2,033.20	1,494.40	1,707.10	1,634.50	1,689.90
Miscellaneous Expenses	113.90	119.00	124.10	180.30	229.70
	12,477.50	14,562.90	16,668.50	18,772.20	21,459.20
Operating Profit (Excl OI)	2,185.10	2,049.60	2,390.70	3,021.80	3,769.30
	78.20	90.30	106.30	200.30	191.60
	2,263.30	2,139.90	2,497.00	3,222.10	3,960.90
Interest	378.60	380.80	449.40	458.50	449.60
PBDT	1,884.70	1,759.10	2,047.60	2,763.60	3,511.30
	600.70	615.40	687.00	757.50	876.10
Profit Before Taxation & Exceptional Items	1,284.00	1,143.70	1,360.60	2,006.10	2,635.20
Exceptional Income / Expenses	294.10		1.90		-19.20
	1,578.10	1,143.70	1,380.50	2,039.10	2,660.90
Provision for Tax	477.00	256.20	445.50	534.00	658.20
	1,101.10	887.50	935.00	1,505.10	2,002.70
Extra items				0.00	0.00
Minority Interest	-52.80	-25.20	-36.40	-59.20	-61.00
Share of Associate	7.30	-43.20
Consolidated Net Profit	1,055.60	819.10	898.60	1,445.90	1,941.70
Profit Balance B/F	593.20	1,600.60	2,059.20	2,772.70	3,941.20
Appropriations	1,648.80	2,419.70	2,957.80	4,218.60	5,882.90
Equity Dividend %	235.00%	300.00%	320.00%	380.00%	400.00%
	73.41	56.96	62.49	100.55	135.03
Adjusted EPS	73.41	56.96	62.49	100.55	135.03

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	71.90	71.90	71.90	71.90	71.90
Share Warrants & Outstandings	8.90	84.90	172.40	285.10	392.00
Total Reserves	5,542.50	6,040.60	6,691.10	7,855.30	9,016.20
Reserve excluding Revaluation Reserve	5,534.70	6,032.80	6,683.30	7,855.30	9,016.20
Revaluation reserve	7.80	7.80	7.80
	5,623.30	6,197.40	6,935.40	8,212.30	9,480.10
Minority Interest	254.40	333.90	385.10	440.60	494.40
Secured Loans	2,408.20	1,923.70	2,231.40	1,967.30	2,424.60
Unsecured Loans	19.00	13.90	4.20	2,449.70	5.50
Deferred Tax Assets / Liabilities	521.50	430.30	438.90	444.90	484.10
Other Long Term Liabilities	1,951.10	2,134.20	2,009.50	2,462.00	2,713.30
Long Term Provisions	1,341.60	1,723.40	349.90	454.40	563.50
Total Non-Current Liabilities	6,241.40	6,225.50	5,033.90	7,778.30	6,191.00
Trade Payables	1,631.80	1,915.60	2,368.60	2,240.50	2,251.80
Other Current Liabilities	421.10	684.80	1,425.90	1,635.90	1,078.30
Short Term Borrowings	208.50	609.10	725.30	521.60	2,953.30
Short Term Provisions	121.90	115.40	144.70	181.40	203.90
Total Current Liabilities	2,383.30	3,324.90	4,664.50	4,579.40	6,487.30
Total Liabilities	14,502.40	16,081.70	17,018.90	21,010.60	22,652.80
Gross Block	11,691.40	12,473.20	14,193.30	16,180.60	18,242.30
Less: Accumulated Depreciation	3,426.70	3,957.50	4,532.80	5,195.20	5,972.90
	8,264.70	8,515.70	9,660.50	10,985.40	12,269.40
	44.00	601.70	844.70	771.00	991.50
Non Current Investments	283.00	281.40	302.10	1,054.50	1,162.20
Long Term Investment	283.00	281.40	302.10	1,054.50	1,162.20
Long Term Loans & Advances	1,735.80	2,178.80	833.90	944.20	1,083.50
Other Non Current Assets	51.80	154.80	66.50	73.30	197.30
Total Non-Current Assets	10,380.80	11,744.70	11,739.20	13,981.20	15,747.00
Currents Investments	501.30	292.20	684.00	1,432.30	1,016.50
Inventories	431.90	390.10	459.80	480.80	542.40
Sundry Debtors	1,767.60	2,234.20	2,514.90	3,016.10	3,484.90
Cash and Bank	1,035.90	775.80	933.80	1,360.20	1,116.80
Other Current Assets	138.40	226.40	258.20	287.40	293.50
Short Term Loans and Advances	246.50	418.30	429.00	452.60	451.70
Total Current Assets	4,121.60	4,337.00	5,279.70	7,029.40	6,905.80
Net Current Assets (Including Current Investments)	1,738.30	1,012.10	615.20	2,450.00	418.50
Total Assets	14,502.40	16,081.70	17,018.90	21,010.60	22,652.80
	602.50	685.10	789.90	1,010.40	1,242.40
Total Debt	2,635.70	2,710.30	3,161.90	5,275.20	5,658.50
	389.89	424.53	469.76	551.27	632.00
Adjusted Book Value	389.89	424.53	469.76	551.27	632.00

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	1,585.40	1,100.50	1,380.50	2,031.40	2,660.90
Adjustment	685.00	1,108.40	1,199.20	1,194.90	1,374.60
Changes In working Capital	-438.10	-450.00	-192.80	-603.90	-574.00
Cash Flow after changes in Working Capital	1,832.30	1,758.90	2,386.90	2,622.40	3,461.50
Cash Flow from Operating Activities	1,628.00	1,376.90	1,920.20	2,136.40	2,855.70
Cash Flow from Investing Activities	-778.20	-870.60	-1,537.20	-3,383.00	-2,148.20
Cash Flow from Financing Activitie	-792.60	-633.00	-311.10	1,319.20	-477.60
Net Cash Inflow / Outflow	57.20	-126.70	71.90	72.60	229.90
Opening Cash & Cash Equivalents	425.20	546.30	433.50	505.50	578.10
Cash & Cash Equivalent of Subsidiaries under liquidations			0.10		3.30
Translation adjustment on reserves / op cash balalces frgn subsidiaries	100.60
Effect of Foreign Exchange Fluctuations		13.80
Closing Cash & Cash Equivalent	583.00	433.40	505.50	578.10	811.30

Ratios

Valuation

57.80

12.47

29.77

4.57

145.32

673.58

Profitability

23.54

21.73

9.17

14.94

7.94

Leverage & Liquidity

0.62

1.06

6.92

Returns

0.24

1.16

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	29.33	29.33	29.33	29.34	29.34	28.02	28.02	28.02	28.02	28.02
	65.29	65.55	65.48	65.26	65.06	65.55	65.28	65.61	65.44	65.48
	5.38	5.12	5.19	5.41	5.61	6.43	6.71	6.37	6.54	6.49
	70.67	70.67	70.67	70.66	70.66	71.98	71.98	71.98	71.98	71.98
No. of Shareholders	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556	1,78,648	1,74,610	1,74,281	1,72,863

Mutual Funds Invested(409)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 254 active funds hold 13.37% in Apollo Hospitals Enterprise Ltd., contributing to ₹15.70K Cr of holdings

Fund				As of
SB SBI Nifty 50 ETFIndex	1,629.89	0.80	19,96,066	Sep '26
HD HDFC Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	860.72	0.79	10,54,093	Sep '26
AX Axis Large Cap Fund - Growth - Direct PlanLarge Cap Fund	849.74	2.91	10,40,646	Sep '26
IP ICICI Prudential Balanced Advantage Fund - Growth - Direct PlanHybrid - Balanced Advantage	569.17	0.79	6,97,048	Sep '26
UT UTI Nifty 50 ETFIndex	558.95	0.80	6,84,525	Sep '26
AX Axis Focused Fund - Growth - Direct PlanEquity - Focused Fund	530.16	5.06	6,49,263	Sep '26
NI Nippon India ETF Nifty 50 BeESIndex	523.22	0.80	6,40,774	Sep '26
SB SBI Flexicap Fund - Growth - Direct PlanFlexi Cap Fund	461.96	2.09	5,65,751	Sep '26
FT Franklin India Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	459.00	2.52	5,62,115	Sep '26
NI Nippon India Pharma Fund - Growth - Direct PlanPharma & Health Care	448.12	4.89	5,48,795	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-10-12	Board Meeting	Quarterly Results
2026-07-16	Board Meeting	Quarterly Results
2026-05-20	Ex Dividend	Rs.10.0000 per share(200%)Final Dividend	2026-08-14	2026-08-14

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareHospital & Healthcare Services

Apollo Hospitals Enterprise Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

Prathap C Reddy

Chairman

₹20.25 Cr

Mar '26

Preetha Reddy

Vice Chairperson

₹9.42 Cr

Mar '26

Suneeta Reddy

Managing Director

₹9.53 Cr

Mar '26

Shobana Kamineni

Non Independent & Non Executive Director

₹8.06 Cr

Mar '26

M B N Rao

Non Executive Independent Director

₹41.00 L

Mar '22

Sangita Reddy

Joint Managing Director

₹9.40 Cr

Mar '26

Vinayak Chatterjee

Non Executive Independent Director

₹38.00 L

Mar '22

Murali Doraiswamy

Non Executive Independent Director

₹57.00 L

Mar '26

Som Mittal

Non Executive Independent Director

₹57.00 L

Mar '26

MBN Rao

Non Executive Independent Director

₹60.00 L

Mar '26

V Kavitha Dutt

Non Executive Independent Director

₹58.00 L

Mar '26

Rama Bijapurkar

Non Executive Independent Director

₹50.00 L

Mar '26

S M Krishnan

Senior Vice President – Finance, Company Secretary & Compliance Officer

—

APOLLOHOSP Latest News

News

6 of 6 articles

EQUITY13 Aug 2026 · 11:20

Apollo Hospitals moves up as its consolidated net profit rises 34% in Q1

The total consolidated income of the company has increased by 20.57% at Rs 7,092.30 crore for Q1FY27

COMPANY13 Aug 2026 · 10:50

Apollo Hospitals’ consolidated net profit rises 34% in Q1

The total consolidated income of the company has increased by 20.57% at Rs 7,092.30 crore for Q1FY27

EQUITY21 May 2026 · 11:35

Apollo Hospitals Enterprise jumps on reporting 36% rise in Q4FY26 consolidated net profit

Consolidated total income of the company increased by 17.62% at Rs 6,649.40 crore for Q4FY26

COMPANY21 May 2026 · 11:27

Apollo Hospitals Enterprise reports 36% rise in Q4FY26 consolidated net profit

Consolidated total income of the company increased by 17.62% at Rs 6,649.40 crore for Q4FY26

EQUITY20 May 2026 · 17:51

Apollo Hospital Ent. reports Profit after tax of Rs 3824.00 Mln, in the March 2026 quarter

EQUITY16 May 2026 · 15:21

Apollo Hospitals Enterprise informs about conference call

Apollo Hospitals Enterprise Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(409)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

APOLLOHOSP Latest News

News